ea0037gp.16.03 | Diabetes and obesity–Clinical obesity and cardiovascular | ECE2015
Hong Ho Cheol
, Hwang Hwan-Jin
, Lee Hyun Jung
, Lee Min Jung
, Seo Ji A
, Kim Sin Gon
, Kim Nan Hee
, Choi Kyung Mook
, Choi Dong Seop
, Baik Sei Hyun
, Yoo Hye Jin
Recently, dipeptidyl peptidase-IV (DPP-IV) inhibitor, a major anti-hyperglycaemic agent, has received substantial attention as a possible therapeutic target for inflammatory diseases such as atherosclerosis. However, the direct molecular mechanisms through which DPP-IV inhibitor mediates anti-inflammatory effects in vascular endothelial cells have not been clarified. The effects of the DPP-IV inhibitor, gemigliptin, were analysed in human umbilical vein endothelial cells (HUVE...